Gnosis Health is a digital health and artificial intelligence company focused on transforming the management of chronic disease through personalised, clinically informed AI systems. Its flagship platform, MAXine, leverages adaptive models, real-time patient data, and evidence-based frameworks to deliver tailored guidance, symptom tracking, and decision support for patients and clinicians. Co-founded by Professor Edward Meinert and Jerrell Schivers, Gnosis Health brings together deep clinical research and advanced engineering to build scalable, patient-centric healthcare solutions.
Gnosis Health
- Health
- Newcastle, United Kingdom
- £1.1m
- gnosisealth.ai
- Update Information
More venture news
- 1 Sept 2026

Scan.comScan.com raises £165m in funding led by Noteus Partners to expand private medical imaging network across the US
Debt & equityHealth - 29 Jul 2026

MiraeMirae lands £4m in funding from Oxford Science Enterprises for conversational AI platform that tracks autoimmune disease between clinic visits
EquityHealth - 28 Jul 2026

DITTODITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
SeedHealth
